latest news in companies
Nvidia Cementing AI Leadership with Record $20 Billion Deal for Groq Assets
Santa Clara, Thursday, 25 December 2025.
In its largest-ever transaction, Nvidia secures Groq’s high-performance chip assets and executive talent for $20 billion, strategically absorbing rival technology while the startup continues operating independently.
Intel Secures Billions in U.S. Investment Following High-Stakes White House Negotiations
Santa Clara, Thursday, 25 December 2025.
After facing presidential criticism, Intel CEO Lip-Bu Tan secured a $5.7 billion federal lifeline, resulting in the U.S. government acquiring a historic ten percent stake in the semiconductor giant.
National Bank Holdings Corporation Wins Federal Approval for Vista Bancshares Acquisition
Denver, Tuesday, 23 December 2025.
With final regulatory clearance secured today, National Bank Holdings Corporation is set to close its Vista Bancshares acquisition by January 7, creating a regional powerhouse with $12.6 billion in assets.
Morgan Stanley Raises Apple Target to $315 on 2027 Earnings Optimism
New York, Tuesday, 23 December 2025.
Morgan Stanley raised Apple’s price target to $315, identifying the stock as a top pick for 2026. The upgrade reflects strong fiscal 2027 earnings forecasts and anticipation of a foldable iPhone.
Electronic Arts Leadership Shaken as Respawn Founder Vince Zampella Dies in Crash
Los Angeles, Tuesday, 23 December 2025.
Vince Zampella, the visionary executive overseeing Electronic Arts’ (NASDAQ: EA) critical first-person shooter portfolio, died Sunday in a Ferrari crash near Los Angeles. As the co-creator of the multi-billion dollar Call of Duty franchise and founder of Respawn Entertainment, Zampella’s sudden passing at 55 creates a significant strategic void for EA. He was pivotal in revitalizing the Battlefield series and sustaining the success of Apex Legends, marking a profound loss for the gaming industry’s leadership landscape.
FDA Clears Novo Nordisk’s Needle-Free Wegovy Pill for January 2026 Launch
Bagsværd, Tuesday, 23 December 2025.
Novo Nordisk secures a market first with FDA approval for oral Wegovy. Launching January 2026, this needle-free option demonstrated 16.6% weight loss, challenging the dominance of injectables.